Last week, President Donald J. Trump sent letters to 17 of the leading pharmaceutical companies outlining steps they must take to lower prescription ...

Analysis by GlobalData characterises an uncertain pharma landscape, though big pharma CEOs allay investor concern.

Just days after telling AstraZeneca how proud he was at its $50 billion investment strategy for the US, President Donald ...